Triple
T4221593
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Cambridge life sciences ecosystem |
E94351
|
entity |
| Predicate | hasKeyCompany |
P51457
|
FINISHED |
| Object |
Cambridge Antibody Technology
Cambridge Antibody Technology was a pioneering UK biotechnology company best known for developing human monoclonal antibody technologies that led to blockbuster therapeutic drugs.
|
E422486
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Cambridge Antibody Technology | Statement: [Cambridge life sciences ecosystem, hasKeyCompany, Cambridge Antibody Technology]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Cambridge Antibody Technology Context triple: [Cambridge life sciences ecosystem, hasKeyCompany, Cambridge Antibody Technology]
-
A.
Genmab
Genmab is a Danish biotechnology company specializing in the development of antibody-based cancer therapies.
-
B.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
C.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
-
D.
Eurofins Scientific
Eurofins Scientific is a global leader in bioanalytical testing services, specializing in food, environmental, pharmaceutical, and clinical laboratory analysis.
-
E.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Cambridge Antibody Technology Triple: [Cambridge life sciences ecosystem, hasKeyCompany, Cambridge Antibody Technology]
Generated description
Cambridge Antibody Technology was a pioneering UK biotechnology company best known for developing human monoclonal antibody technologies that led to blockbuster therapeutic drugs.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Cambridge Antibody Technology Target entity description: Cambridge Antibody Technology was a pioneering UK biotechnology company best known for developing human monoclonal antibody technologies that led to blockbuster therapeutic drugs.
-
A.
Genmab
Genmab is a Danish biotechnology company specializing in the development of antibody-based cancer therapies.
-
B.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
C.
Lonza
Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
-
D.
Eurofins Scientific
Eurofins Scientific is a global leader in bioanalytical testing services, specializing in food, environmental, pharmaceutical, and clinical laboratory analysis.
-
E.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69b3451997e08190851db4a9a588837d |
completed | March 12, 2026, 10:58 p.m. |
| NER | Named-entity recognition | batch_69b34f7d20b48190a404638c68c31026 |
completed | March 12, 2026, 11:42 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b59642720c81908e68a56b3d30eef9 |
completed | March 14, 2026, 5:09 p.m. |
| NEDg | Description generation | batch_69b596cb73ac81909f83daca406ad8c4 |
completed | March 14, 2026, 5:11 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69b59a9c386081909c21ad554d403bfc |
completed | March 14, 2026, 5:27 p.m. |
Created at: March 12, 2026, 11:04 p.m.